Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007 · see citing works

Depression, chronic diseases, and decrements in health: results from the World Health Surveys

Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · see citing works

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works

Behavioral despair in mice: a primary screening test for antidepressants.

Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,275 · see citing works

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J. T., Fowler, R. A., Finn, P. V., Anderson, W. F., Zauber, A. G., Hawk, E. T., & Bertagnolli, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,046 · see citing works

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · see citing works

Resolvins

Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · see citing works

New approaches to antidepressant drug discovery: beyond monoamines

Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · see citing works

Assessing antidepressant activity in rodents: recent developments and future needs

Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · see citing works

Cytokine Production and Treatment Response in Major Depressive Disorder

Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · see citing works

INCREASED SERUM IL-6 AND IL-1 RECEPTOR ANTAGONIST CONCENTRATIONS IN MAJOR DEPRESSION AND TREATMENT RESISTANT DEPRESSION

Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728 · see citing works

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670 · see citing works

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621 · see citing works

Prevalence of suicide ideation and suicide attempts in nine countries

Weissman, M. M., Bland, R. C., CANINO, G. J., Greenwald, S., Hwu, H., Joyce, P. R., Karam, E. G., Lee, C.-Y., Lellouch, J., Lépine, J., et al. (1999) · Psychological Medicine · doi:10.1017/s0033291798007867 · Cited by 583 · see citing works

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527 · see citing works

The effects of chronic antidepressant treatment in an animal model of anxiety

Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437 · see citing works

Deaths: final data for 2002.

Kochanek, K. D., Murphy, S. L., Anderson, R. N., & Scott, C. (2004) · PubMed · Cited by 385 · see citing works

Suicide and Aging I: Patterns of Psychiatric Diagnosis

Conwell, Y., & Brent, D. A. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295001943 · Cited by 237 · see citing works

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229 · see citing works

Novel Drugs and Therapeutic Targets for Severe Mood Disorders

Mathew, S. J., Manji, H. K., & Charney, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301652 · Cited by 222 · see citing works

Depression as a major component of public health for older adults.

Chapman, D. P., & Perry, G. S. (2008) · PubMed Central · Cited by 206 · see citing works

Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?

Rapoport, S. I., & Bosetti, F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.592 · Cited by 188 · see citing works

Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain

Bosetti, F., Rintala, J., Seemann, R., Rosenberger, T. A., Contreras, M. A., Рапопорт, С. И., & Chang, M. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001111 · Cited by 137 · see citing works

Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression

Sluzewska, A., Sobieska, M., & Rybakowski, J. K. (2008) · Neuropsychobiology · doi:10.1159/000119332 · Cited by 134 · see citing works

Molecular Pathways Associated with Stress Resilience and Drug Resistance in the Chronic Mild Stress Rat Model of Depression—a Gene Expression Study

Bergström, A., Jayatissa, M. N., Thykjær, T., & Wiborg, O. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0065-9 · Cited by 123 · see citing works

Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease

Hennekens, C. H., Sacks, F. M., Tonkin, A. M., Jukema, J. W., Byington, R. P., Pitt, B., Berry, D. A., Berry, S. M., Ford, N. F., Walker, A. J., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.1.40 · Cited by 111 · see citing works

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

Brunello, N., Alboni, S., Capone, G., Benatti, C., Blom, J. M. C., Tascedda, F., Kriwin, P., & Mendlewicz, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00004 · Cited by 104 · see citing works

Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance

Benedetti, F., Lucca, A., Brambilla, F., Colombo, C., & Smeraldi, E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00255-5 · Cited by 73 · see citing works

Treatment resistant depression and Axis I co-morbidity

PETERSEN, T., Gordon, J., Kant, A. J., D, M. F. M., Rosenbaum, J. F., & Nierenberg, A. A. (2001) · Psychological Medicine · doi:10.1017/s0033291701004305 · Cited by 52 · see citing works

ASPIRIN USE, DEPRESSION, AND COGNITIVE IMPAIRMENT IN LATER LIFE: THE HEALTH IN MEN STUDY

Almeida, O. P., Alfonso, H. S., Jamrozik, K. D., Hankey, G. J., & Flicker, L. A. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02827.x · Cited by 44 · see citing works

Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors

Lieb, J. (1983) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(83)90039-5 · Cited by 40 · see citing works

Effects of acute and chronic treatment with fluoxetine on stress-induced hyperthermia in telemetered rats and mice

Conley, R. K., & Hutson, P. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.063 · Cited by 34 · see citing works

[Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].

Poul, E. L., Lima, L. V., Laporte, A., et al. (1995) · PubMed · Cited by 14 · see citing works

Aspirin for Primary Prevention of Coronary Heart Disease: Using the Framingham Risk Score to Improve Utilization in a Primary Care Clinic

Romero, S. C., Rosa, K. M. D., & Linz, P. E. (2008) · Southern Medical Journal · doi:10.1097/smj.0b013e318178e58e · Cited by 13 · see citing works

Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease: Randomized and Observational Comparisons of Secondary Prevention Trials and Their Meta-analyses

Samson, R. (2005) · Perspectives in Vascular Surgery · doi:10.1177/153100350501700115 · Cited by 2 · see citing works

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529 · see citing works

Is depression an inflammatory disorder?

Raison, C. L., & Miller, A. H. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0232-0 · Cited by 524 · see citing works

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · see citing works

Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?

Jeon, S. W., & Kim, Y. K. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.283 · Cited by 247 · see citing works

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107 · see citing works

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works

Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial

Berk, M., Woods, R. L., Nelson, M. R., Shah, R. C., Reid, C. M., Storey, E., Fitzgerald, S., Lockery, J. E., Wolfe, R., Mohebbi, M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1214 · Cited by 89 · see citing works

BDNF and COX-2 participate in anti-depressive mechanisms of catalpol in rats undergoing chronic unpredictable mild stress

Wang, J.-M., Yang, L.-H., Zhang, Y.-Y., Niu, C.-L., Cui, Y., Feng, W.-S., & Wang, G.-F. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.08.008 · Cited by 72 · see citing works

Domestic clinical applications of fluoxetine during 10 years

Dai-hui, P. (2005) · Chinese Journal of New Drugs and Clinical Remedies

Seizures associated with fluoxetine therapy

Prasher, V. P. (1993) · Seizure · doi:10.1016/s1059-1311(05)80148-7 · Cited by 30 · see citing works

Meta-ananlysis of Comparative Study on Fluoxetine in the Treatment of Obsessive-compulsive Disorder

Chang-qu, C. (2012) · Chinese Journal of Clinical Rational Drug Use

Decreased Aggressive and Locomotor Behaviors in <i>Betta Splendens</i> after Exposure to Fluoxetine

Kohlert, J. G., Mangan, B. P., Kodra, C., et al. (2012) · Psychological Reports · doi:10.2466/02.13.pr0.110.1.51-62 · Cited by 74 · see citing works

선택적 세로토닌 재흡수 차단제인 fluoxetine 이 우울증을 야기시킨 쥐의 수동적 회피 학습에 미치는 영향

조선영, 이기철, 이정호, et al. (1996) · 한국심리학회지: 인지 및 생물